WHITE BEAR LAKE, Minn., June 11, 2025 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices that leverage the ear's natural anatomy, today announced that Brent Lucas, CEO of Envoy Medical, will present live at the Life Sciences Virtual Investor Frum hosted by VirtualInvestorConferences.com, on June 12th, 2025. DATE: June 12th TIME: 3pm Eastern LINK: REGISTER HERE Available for 1x1 meetings: June 12th throu ...

Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up Positive momentum from the trial's first stage encouraging Company to accelerate plans for expansion and commercialization June 10, 2025 8:30 AM EDT | Source: Envoy Medical, Inc. ear instead of a microphone to capture sound. The device is powered by a rechargeable battery and has an external charger to charge the internal device when necessary. In addition, patients are given a ...

Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of TrialMay 13, 2025 9:15 AM EDT | Source: Envoy Medical, Inc.White Bear Lake, Minnesota--(Newsfile Corp. - May 13, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices that leverage the ear's natural anatomy, today announces achieving the important milestone of successful activation of all 10 study partic ...

Envoy Medical Reports on First Quarter 2025 ResultsCompany Provides Update on Its Pivotal Clinical Study for Fully Implanted Cochlear ImplantMay 01, 2025 4:30 PM EDT | Source: Envoy Medical, Inc.White Bear Lake, Minnesota--(Newsfile Corp. - May 1, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced its corporate and financial results for the first quarter ended March 31, 2025, as well ...